J1553 HCPCS code: Injection, immune globulin (yimmugo), 100 mg
J1553 is the HCPCS Level II code for injection, immune globulin (yimmugo), 100 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2026-04-01 |
| Last action effective | 2026-04-01 |
Medicare policy articles for this code
- A52509: Intravenous Immune Globulin - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance
- A56786: Billing and Coding: Immune Globulin (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
- A57187: Billing and Coding: Immune Globulin Intravenous (IVIg) (Noridian Healthcare Solutions, LLC (MAC - Part A, MAC - Part B))
- A57778: Billing and Coding: Immune Globulin (First Coast Service Options, Inc. (MAC - Part A, MAC - Part B))
Covered diagnoses (150 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| D80.0 | Hereditary hypogammaglobulinemia | 4 |
| D80.2 | Selective deficiency of immunoglobulin A [IgA] | 4 |
| D80.3 | Selective deficiency of immunoglobulin G [IgG] subclasses | 4 |
| D80.4 | Selective deficiency of immunoglobulin M [IgM] | 4 |
| D80.5 | Immunodeficiency with increased immunoglobulin M [IgM] | 4 |
| D80.6 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia | 4 |
| D80.7 | Transient hypogammaglobulinemia of infancy | 4 |
| D81.0 | Severe combined immunodeficiency [SCID] with reticular dysgenesis | 4 |
| D81.1 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers | 4 |
| D81.2 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers | 4 |
Showing 10 of 150. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for J1553
- April 2026: Code appears in this HCPCS release
- 2026-04-01: J1553 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1553?
J1553 is the HCPCS Level II code for injection, immune globulin (yimmugo), 100 mg. Short descriptor: "Inj yimmugo 100 mg".
Does Medicare cover J1553?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J1553?
Medicare policy articles that cite J1553 list 150 covered ICD-10-CM diagnosis codes across 4 articles. The most cited include D80.0 (Hereditary hypogammaglobulinemia), D80.2 (Selective deficiency of immunoglobulin A [IgA]), D80.3 (Selective deficiency of immunoglobulin G [IgG] subclasses). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
Related J15 codes
- J1551 — Injection, immune globulin (cutaquig), 100 mg
- J1552 — Injection, immune globulin (alyglo), 500 mg
- J1554 — Injection, immune globulin (asceniv), 500 mg
- J1555 — Injection, immune globulin (cuvitru), 100 mg
- J1556 — Injection, immune globulin (bivigam), 500 mg
- J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1558 — Injection, immune globulin (xembify), 100 mg
- J1559 — Injection, immune globulin (hizentra), 100 mg
- J1560 — Injection, gamma globulin, intramuscular, over 10 cc
- J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562 — Injection, immune globulin (vivaglobin), 100 mg
- J1566 — Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1553
- Watch J1553 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1553
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.